ImageneBio, Inc.
IMA
$5.52
-$0.04-0.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | -- | -- | 800.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | -- | -- | 800.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 0.00 | -- | -- | 800.00K |
| SG&A Expenses | 6.12M | 5.23M | 11.04M | 1.71M | 2.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.08M | 8.50M | 26.59M | 7.36M | 6.80M |
| Operating Income | -12.08M | -8.50M | -26.59M | -7.36M | -6.00M |
| Income Before Tax | -10.61M | -7.18M | -24.85M | -7.59M | -6.08M |
| Income Tax Expenses | 10.00K | -276.00K | -74.00K | -- | -- |
| Earnings from Continuing Operations | -10.62M | -6.91M | -24.78M | -7.59M | -6.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.62M | -6.91M | -24.78M | -7.59M | -6.08M |
| EBIT | -12.08M | -8.50M | -26.59M | -7.36M | -6.00M |
| EBITDA | -11.98M | -8.11M | -26.59M | -7.36M | -5.99M |
| EPS Basic | -0.95 | -0.62 | -2.29 | -7.60 | -3.80 |
| Normalized Basic EPS | -0.59 | -0.40 | -1.39 | -3.36 | -1.58 |
| EPS Diluted | -0.95 | -0.62 | -2.29 | -7.60 | -3.80 |
| Normalized Diluted EPS | -0.59 | -0.40 | -1.39 | -3.36 | -1.58 |
| Average Basic Shares Outstanding | 11.21M | 11.18M | 11.18M | 1.41M | 2.40M |
| Average Diluted Shares Outstanding | 11.21M | 11.18M | 11.18M | 1.41M | 2.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |